Premier Resolution
Thalassemia and hemoglobin variant detection
Approved/CommercialMarketed globally
Key Facts
Indication
Thalassemia and hemoglobin variant detection
Phase
Approved/Commercial
Status
Marketed globally
Company
About Trinity Biotech
Trinity Biotech is a publicly traded diagnostics company focused on transforming healthcare through innovative testing solutions. The company has achieved significant milestones, including regaining compliance with Nasdaq listing requirements and securing regulatory approvals for offshored manufacturing of its flagship HIV test. With a diversified portfolio spanning infectious disease, autoimmune, hemoglobin, and clinical chemistry testing, Trinity Biotech aims to improve patient outcomes globally while executing a strategic transformation to enhance financial performance.
View full company profile